Comparison of truncated human angiotensin-converting enzyme 2 (hACE2) expression in pET28a(+) versus pET-SUMO vector and two Escherichia coli strains

Bourgonje, 2020, H. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19), J Pathol, 251, 228, 10.1002/path.5471 Krishnamurthy, 2021, Soluble ACE2 as a potential therapy for COVID-19. American journal of physiology, Cell physiology, 320, 279, 10.1152/ajpcell.00478.2020 Haschke, 2013, Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects, Clin Pharmacokinet, 52, 783, 10.1007/s40262-013-0072-7 Turner, 2015, In chapter 25 - ACE2 cell biology, regulation, and physiological functions Morgan, 2021, Stapled. ACE2 peptidomimetics designed to target the SARS-CoV-2 spike protein do not prevent virus internalization, Pept. Sci., 113, 10.1002/pep2.24217 Ruiz de Eguilaza, 2020, Electrochemical detection of viruses and antibodies: a mini review, Electrochem Commun, 116 Lubbe, 2020, ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV, Clin Sci, 134, 2851, 10.1042/CS20200899 Vezza, 2021, An electrochemical SARS-CoV-2 biosensor inspired by glucose test strip manufacturing processes, Chem Commun, 57, 3704, 10.1039/D1CC00936B de Lima, 2021, Minute-scale detection of SARS-CoV-2 using a low-cost biosensor composed of pencil graphite electrodes, Proc Natl Acad Sci USA, 118, 10.1073/pnas.2106724118 Mavrikou, 2021, Angiotensin-converting enzyme 2 (ACE2) as a novel biorecognition element in A cell based biosensor for the ultra-rapid, ultra-sensitive detection of the SARS-CoV-2 S1 spike protein antigen, Chemosensors, 9, 341, 10.3390/chemosensors9120341 Long, 2015, Soluble expression, purification, and characterization of active recombinant human tissue plasminogen activator by auto-induction in E. coli, BMC Biotechnol, 15, 13, 10.1186/s12896-015-0127-y Abdul Basit, 2021, Truncated human angiotensin converting enzyme 2; a potential inhibitor of SARS-CoV-2 spike glycoprotein and potent COVID-19 therapeutic agent, J Biomol Struct Dyn, 39, 3605, 10.1080/07391102.2020.1768150 Damas, 2020, Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates, Proc Natl Acad Sci USA, 117, 22311, 10.1073/pnas.2010146117 Rosano, 2014, Recombinant protein expression in Escherichia coli: advances and challenges, Front Microbiol, 5, 1 Shilling, 2020, Improved designs for pET expression plasmids increase protein production yield in Escherichia coli, Commun Biol, 3 Gao, 2021, An efficient system to generate truncated human angiotensin converting enzyme 2 (hACE2) capable of binding RBD and spike protein of SARS-CoV2, Protein Expr Purif, 184, 10.1016/j.pep.2021.105889 Invitrogen, 2010 Makino, 2011, Strain engineering for improved expression of recombinant proteins in bacteria, Microb Cell Factories, 10, 32, 10.1186/1475-2859-10-32 Fathi-Roudsari, 2016, Comparison of three Escherichia coli strains in recombinant production of reteplase, Avicenna J Med Biotechnol (AJMB), 8, 16 A Hoffmann, 2020, SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell, 181, 271, 10.1016/j.cell.2020.02.052 Wang, 2020, Structural and functional basis of SARS-CoV-2 entry by using human ACE2, Cell, 181, 894, 10.1016/j.cell.2020.03.045 Shang, 2020, Structural basis of receptor recognition by SARS-CoV-2, Nature, 581, 221, 10.1038/s41586-020-2179-y Lan, 2020, Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor, Nature, 581, 215, 10.1038/s41586-020-2180-5 Francis, 2010, Strategies to optimize protein expression in E. coli, Curr Protoc Protein Sci, 1 Tingting Zhao, 2021, Enhancement of solubility, purification, and inclusion body refolding of active human mitochondrial aldehyde dehydrogenase 2, ACS Omega, 6, 12004, 10.1021/acsomega.1c00577 Wang, 2010, High-level expression and purification of soluble recombinant FGF21 protein by SUMO fusion in Escherichia coli, BMC Biotechnol, 10, 14, 10.1186/1472-6750-10-14 Camps, 2010, Modulation of ColE1-like plasmid replication for recombinant gene expression, Recent Pat DNA Gene Sequences, 4, 58, 10.2174/187221510790410822